Organometallics
Article
2
3
(2c) (210 mg, 0.50 mmol) in THF (2 mL). The reaction mixture was
stirred for 2 h at 80 °C. After removing the volatiles under reduced
pressure, the resulting solid was dried in vacuo to afford a white
powder of P(NIMes)tBu2 in quantitative yield. 1H NMR (C6D6,
400.1 MHz) δ (ppm) = 6.84 (s, 4H, Mes-H); 2.30 (s, 12H, Mes-
CH3); 2.12 (s, 6H); 1.14 (s, 6H, CH3); 1.03 (d, 3JPH = 10.5 Hz, 18H,
tert-butyl-CH). 13C{1H} NMR (C6D6, 100.6 MHz) δ (ppm) = 148.3
(d, JPC = 24 Hz, N2CN); 137.9−137.7 (m); 133.9; 129.1; 115.4; 33.7
(d, JPC = 23 Hz); 28.8 (d, JPC = 16 Hz); 21.2; 18.8 (d, JPC = 2 Hz);
9.1..31P{1H} NMR (C6D6, 162.0 MHz): δ (ppm) = 74.0. 31P NMR
(C6D6, 162.0 MHz): δ (ppm) = 74.0 (m). HRMS (ESI-TOFMS): m/
z [M + H]+ 392.34952 (calculated 392.35021).
General Procedure for [Au(IAP)Cl]. The respective phosphines
(0.50 mmol) and [Au(tht)Cl] (0.50 mmol) were dissolved in THF (2
mL) and stirred for 1 h at room temperature. The volatiles were
removed in vacuo and the resulting white solid was dried for 1 h at
room temperature to afford the gold(I) complexes [Au(IAP)Cl] in
quantitative yield.
CH3); 1.18 (dsept, JPH = 14.0 Hz, JHH = 7.2 Hz, 2H, Isopropyl-
CH); 0.77 (dd, 3JPH = 17.9 Hz, 3JHH = Hz, 6H, Isopropyl-CH3); 0.64
(dd, JPH = 17.0 Hz, JHH = 7.0 Hz, 6H, isopropyl-CH3). 13C{1H}
NMR (C6D6, 100.6 MHz) δ (ppm) = 145.0 (d, JPC = 4.3 Hz, N2CN);
139.3; 136.9; 131.1; 129.4; 117.3; 30.7 (d, JPC = 50.0 Hz); 21.2; 18.6;
17.9 (d, JPC = 3.0 Hz); 17.4; 9.1. 31P{1H} NMR (C6D6, 162.0 MHz):
δ (ppm) = 66.5. 31P NMR (C6D6, 162.0 MHz): δ (ppm) = 66.5 (m).
HRMS (ESI-TOFMS): m/z [M + H]+ 696.25521 (calculated
696.25432).
[Au{P(NIMes)2iPr}Cl] (4f). Prepared according to general
procedure. H NMR (C6D6, 400.1 MHz): δ (ppm) = 6.97 (s, 8H,
Mes-H); 2.29 (s, 12H, CH3); 2.19 (s, 12H, CH3); 2.01 (s, 12H,
CH3); 1.37 (s, 12H, CH3); 0.70 (dd, JPH = 17.5 Hz, JHH = 6.8 Hz,
3H, isopropyl-CH3). 13C{1H} NMR (C6D6, 100.6 MHz) δ (ppm) =
142.0 (d, JPC = 7.6 Hz, N2CN); 138.4; 137.6; 137.5; 132.2; 130.2;
129.7; 116.1; 35.7 (d, JPC = 65.5 Hz); 21.4; 18.8 (d, JPC = 31.8 Hz);
16.9; 9.0. 31P{1H} NMR (C6D6, 162.0 MHz): δ (ppm) = 44.1. 31P
3
3
1
3
3
3
NMR (C6D6, 162.0 MHz): δ (ppm) = 44.1 (sept, JPH = 17.5 Hz).
HRMS (ESI-TOFMS): m/z [M + H]+ 999.43418 (calculated
999.42786).
[Au{P(NsIDipp)iPr2}Cl] (4a). Prepared according to general
1
procedure B. H NMR (CDCl3, 400.1 MHz) δ (ppm) = 7.40 (t,
3JHH = 7.7 Hz, 2H, p-Mes-H); 7.23 (d, 3JHH = 7.7 Hz, 4H, m-Mes-H);
3.95 (s, 4H, CH2); 3.29 (sept, 3JHH = 6.8 Hz, 4H, Mes-CH); 1.35 (dd,
3JHH = 6.8 Hz, J = 57.3 Hz, 24H, CH3); 1.30−1.25 (m, 2H, CH); 0.76
[Au{P(NIiPr)iPr2}Cl] (4g). Prepared according to the general
procedure. 1H NMR (C6D6, 400.1 MHz) δ (ppm) = 5.09 (sept, JHH
=
7.2 Hz, 2H, NCHMe2), 1,77 (m, 2H, PCHMe2), 1.57 (s, 6H, CH3),
1.13 (d, JHH = 7.2 Hz, 12H, NCH(CH3)2), 1.13−1.03 (m, 12 H,
PCH(CH3)2). 13C{1H} NMR (C6D6, 100.6 MHz) δ (ppm) = 147.7
(d, JPC = 3.2 Hz, N2CN); 117.5; 47.2; 31.3; 30.8; 21.6; 18.6; 18.7;
17.2; 17.2; 9.9. 31P{1H} NMR (C6D6, 162.0 MHz): δ (ppm) = 73.5.
31P NMR (C6D6, 162.0 MHz): δ (ppm) = 73.5 (m). HRMS (ESI-
TOFMS): m/z [M + H]+ 754.33239 (calculated 754.33257).
[Au2{P(NIMes)tBu2}2Cl]OTf (5). 4d (44 mg, 0.06 mmol) and
AgOTf (16 mg, 0.06 mmol) were stirred in CH2Cl2 (2 mL) at room
temperature for 5 min. The solid components were filtered off and the
volatiles were removed in vacuo. Colorless crystals were obtained by
diffusion of n-pentane into a concentrated solution of 5 in
3
(ddd, J = 46.7 H J = 7.0 Hz, JPH = 17.7 Hz, 12H). 13C{1H} NMR
(CDCl3, 100.6 MHz) δ (ppm) = 155.8 (d, JPC = 2.0 Hz, N2CN);
147.6; 134.6; 129.4; 128.3; 124.6; 49.2; 30.4 (d, J = 48 Hz) 28.7;
26.1; 23.8; 17.8 (d, J = 2 Hz), 17.5 (d, J = 3 Hz). 31P{1H} NMR
(CDCl3, 162.0 MHz): δ (ppm) = 69.6. 31P NMR (CDCl3, 162.0
MHz): δ (ppm) = 69.6 (m). HRMS (ESI-TOFMS): m/z [M + H]+
754.33239 (calculated 754.33257).
[Au{P(NIDipp)iPr2}Cl] (4b). Prepared according to general
1
procedure. H NMR (CDCl3, 400.0 MHz) δ (ppm) = 7.45 (t, JHH
= 7.7 Hz, 4H, p-H); 7.26 (d, JHH = 7.7 Hz, 4H, m-H); 6.54 (s, 2H,
Imidazole-H); 2.97 (sep, JHH = 6.9 Hz, 4H, DippiPr-H); 1.38 (d, JHH
1
fluorobenzene. H NMR (CD2Cl2, 400.0 MHz) δ (ppm) = 7.00 (s,
= 6.9 Hz, 12H, Dipp-iPr-CH3); 1.23 (m, 2H, P-iPr-H); 1.16 (d, JHH
=
8H, Mes-H); 2.37 (s, 12H, CH3); 2.13 (s, 24H, CH3); 1.71 (s, 12H,
6.9 Hz, 12H, Dipp-iPr-CH3); 0.74 (dd, JPH = 18.0 Hz, JHH = 7.1 Hz,
6H, P-iPrCH3); 0.74 (dd, JPH = 17.4 Hz, JHH = 7.1 Hz, 6H, P-iPr-
CH3). 13C{1H} NMR (CDCl3, 100.6 MHz) δ (ppm) = 147.8 ((N)2-
CN); 132.8; 130.2; 124.2; 116.6; 31.0; 30.5; 28.7; 25.4; 23.0; 17.4
(m). 31P NMR (CDCl3, 161.9 MHz): δ (ppm) = 69.4 (m). 31P{1H}
NMR (CDCl3, 161.9 MHz): δ (ppm) = 69.4. HRMS (ESI-TOFMS):
m/z [M + Na]+ 774.29898 (calculated 774.29941).
CH3); 0.91 (d, JPH = 15.9 Hz, 36H, tert-buty-CH3). 13C{1H} NMR
3
(CDCl3, 100.6 MHz) δ (ppm) = 144.2; 140.0; 136.9; 131.7; 130.3;
118.1; 38.7 (d, JPC = 49.1 Hz); 28.1 (d, JPC = 6.6 Hz); 21.7; 18.5; 9.1.
19F NMR (CD2Cl2, 376.4 MHz): δ (ppm) = −78.9. 19F{1H} NMR
(CD2Cl2, 376.4 MHz): δ (ppm) = −78.9. 31P NMR (CD2Cl2, 161.9
MHz): δ (ppm) = 75.7 (br). 31P{1H} NMR (CD2Cl2, 161.9 MHz): δ
(ppm) = 75.7 (br). HRMS (ESI-TOFMS): m/z [M-OTf]+
1411.58863 (calculated 1411.58728).
[Au{P(NIDipp)tBu2}Cl] (4c). The reaction mixture of 3c (59%,
534 mg, 0.50 mmol) and [Au(tht)Cl] (160 mg, 0.50 mmol) were
dissolved in THF (2 mL) and stirred for 1 h at room temperature.
Then the volatiles were removed in vacuo for 1 h at room
temperature. The impurities from the synthesis of 3c were separated
from 4c by washing the isolated solid with n-hexane (3 × 10 mL). 1H
[Au{P(NIMes)tBu2}(py)](SbF6) (6). 4d (72 mg, 0.1 mmol) and
pyridine (78 μL, 1.0 mmol) were dissolved in CH2Cl2 (2 mL).
AgSbF6 (34 mg, 0.1 mmol) was added and the reaction mixture was
stirred at room temperature overnight. The solid components were
filtered off and n-pentane (20 mL) was added to the solution,
resulting in a white precipitate, which was isolated by filtration,
washed with n-pentane (3 × 10 mL), and dried in vacuo for 1 min.
3
NMR (CDCl3, 400.1 MHz) δ (ppm) = 7.51 (t, JHH = 7.8 Hz, 2H,
3
Dipp-H); 7.28 (d, JH3H = 7.8 Hz, 4H,Dipp-H); 6.44 (s, 2H,
3
N(CH)2N); 2.96 (sept, JHH = 6.8 Hz, 4H, Dipp-CH); 1.39 (d, JHH
1
3
Colorless crystals of 6 were obtained from CH2Cl2/n-pentane. H
= 6.8 Hz, 12H, CH(CH3)2); 1.15 (d, JHH = 6.8 Hz, 12H,
3
CH(CH3)2); 0.95 (d, JPH = 15.7 Hz, 18H). 13C{1H} NMR
NMR (CD2Cl2, 400.0 MHz) δ (ppm) = 8.21 (s, br, 2H, pyridine);
8.10 (s, br, 1H, pyridine); 7.73 (s, br, 2H, pyridine); 6.91 (s, 4H, Mes-
H); 2.18 (s, 12H, CH3); 1.99 (s, 6H, CH3); 1.70 (s, 6H, CH3); 1.01
(CDCl3, 100.6 MHz) δ (ppm) = 146.1, 133.5, 130.5, 124.6, 116.8,
77.0, 38.1, 37.6, 28.9, 28.0, 27.9, 26.0, 22.3. 31P{1H} NMR (CDCl3,
162.0 MHz): δ (ppm) = 80.2. 31P NMR (CDCl3, 162.0 MHz): δ
(ppm) = 80.2 (m).
(d, JPH = 16.0 Hz, tert-buty-CH3). 13C{1H} NMR (CDCl3, 100.6
3
MHz) δ (ppm) = 150.5 (br, pyridine) 144.5 c (d, JPC = 2.0 Hz,
N2CN); 141.4 (br, pyridine); 139.6; 137.3; 131.9; 129.9; 127.0 (br,
pyridine); 118.3; 38.3 (d, JPC = 47.0 Hz); 28.9 (d, JPC = 6.1 Hz), 20.9;
18.5; 9.1. 19F NMR (CD2Cl2, 376.4 MHz): δ (ppm) = −123.97 (m).
19F{1H} NMR (CD2Cl2, 376.4 MHz): δ (ppm) = −123.97 (m); 31P
NMR (CDCl3, 161.9 MHz): δ S67(ppm) = 73.5 (m). 31P{1H} NMR
(CDCl3, 161.9 MHz): δ (ppm) = 73.5.
General Procedure for the Catalysis. The [Au(IAP)Cl] (0.09
mmol, 1 equiv) and AgBF4 (0.09 mmol, 1 equiv) were dissolved in
MeCN (3 mL) and stirred for 10 min at room temperature. The
solution was then filtered over a glass microfiber filter, and a standard
solution (0.018 M) in MeCN was prepared. [Au(PPh3)Cl] was used
exactly the same way but with twice the amount of solvents due to
solubility, resulting in a 0.009 M standard solution. Phenylacetylene
[Au{P(NIMes)tBu2}Cl] (4d). Prepared according to general
1
procedure. H NMR (CDCl3, 400.1 MHz): δ (ppm) = 6.99 (s, 4H,
Mes-H); 2.37 (s, 6H, CH3); 2.13 (s, 12H, CH3); 1.69 (s, 6H, CH3);
1.37 (s, 12H, CH3); 0.90 (d, 3JPH = 15.6 Hz, tert-buty-CH3). 13C{1H}
NMR (CDCl3, 100.6 MHz) δ (ppm) = 144.1 (d, JPC = 2.5 Hz,
N2CN); 139.5; 136.2; 131.3; 129.9; 117.0; 37.9 (d, JPC = 44.6 Hz),
27.9 (d, JPC = 6.9 Hz), 21.4; 18.3; 9.0. 31P{1H} NMR (CDCl3, 162.0
MHz): δ (ppm) = 78.9. 31P NMR (CDCl3, 162.0 MHz): δ (ppm) =
78.9 (m). HRMS (ESI-TOFMS): m/z [M + H]+ 724.28662
(calculated 724.28562).
[Au{P(NIMes)iPr2}Cl] (4e). Prepared according to general
1
procedure. H NMR (C6D6, 400.1 MHz) δ (ppm) = 6.98 (s, 4H,
Mes-H); 2.34 (s, 6H, 2xCH3); 2.18 (s, 12H, Mes-CH3); 1.76 (s, 6H,
G
Organometallics XXXX, XXX, XXX−XXX